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Abstract Purple acid phosphatases (PAPs) are a group of
heterovalent binuclear metalloenzymes that catalyze the
hydrolysis of phosphomonoesters at acidic to neutral pH.
While the metal ions are essential for catalysis, their pre-
cise roles are not fully understood. Here, the Fe(III)Ni(II)
derivative of pig PAP (uteroferrin) was generated and its
properties were compared with those of the native
Fe(III)Fe(II) enzyme. The kcat of the Fe(III)Ni(II) deriva-
tive (approximately 60 s–1) is approximately 20% of that of
native uteroferrin, and the Ni(II) uptake is considerably
faster than the reconstitution of full enzymatic activity,
suggesting a slow conformational change is required to
attain optimal reactivity. An analysis of the pH dependence
of the catalytic properties of Fe(III)Ni(II) uteroferrin indi-
cates that the l-hydroxide is the likely nucleophile. Thus,
the Ni(II) derivative employs a mechanism similar to that
proposed for the Ga(III)Zn(II) derivative of uteroferrin, but
different from that of the native enzyme, which uses a
terminal Fe(III)-bound nucleophile to initiate catalysis.
Binuclear Fe(III)Ni(II) biomimetics with coordination
environments similar to the coordination environment of
uteroferrin were generated to provide both experimental
benchmarks (structural and spectroscopic) and further
insight into the catalytic mechanism of hydrolysis. The
data are consistent with a reaction mechanism employing
an Fe(III)-bound terminal hydroxide as a nucleophile,
similar to that proposed for native uteroferrin and various
related isostructural biomimetics. Thus, only in the utero-
ferrin-catalyzed reaction are the precise details of the
catalytic mechanism sensitive to the metal ion composi-
tion, illustrating the significance of the dynamic ligand
environment in the protein active site for the optimization
of the catalytic efficiency.
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Introduction
Purple acid phosphatases (PAPs) belong to the family of
binuclear metallohydrolases, a large group of enzymes
involved in a range of metabolic functions [1, 2]. Members
of this family have emerged as promising candidates for
the development of drugs and bioremediation agents. PAPs
catalyze the hydrolysis of a broad range of phosphorylated
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substrates at acidic to neutral pH, and they require a het-
erovalent bimetallic active site for reactivity [1, 2]. PAPs
isolated from mammalian organisms are approximately
35 kDa monomers with a redox-active Fe(III)Fe(II/III)
center and a highly conserved amino acid sequence with at
least 85% identity across species [1–5]. Homodimeric plant
PAPs, extracted from red kidney bean, soybean and sweet
potato [6–8], have a subunit molecular mass of approxi-
mately 55 kDa, and the amino acid sequences are
homologous, sharing at least 65% identity [5, 7]. The metal
ion composition in plant PAPs is either Fe(III)Zn(II) or
Fe(III)Mn(II) [6–9]. Common to all PAPs is the charac-
teristic purple color, which is due to a charge transfer
transition (kmax = 510–560 nm; e * 3,000–4,000 M
–1 cm–1)
in the active site from a conserved tyrosine ligand to the
ferric ion [10–12].
The metal ions in the active sites of PAPs are coordi-
nated by seven invariant amino acid side chains (Fig. 1).
Apart from the chromophoric tyrosine ligand the Fe(III) is
coordinated to the nitrogen atom of a histidine and the
oxygen atoms of two aspartate residues, one of which
bridges the two metal ions. The divalent metal ion is
coordinated to the oxygen atom of the bridging aspartate,
the nitrogen atoms of two histidine residues and an
asparagine oxygen atom. On the basis of recent spectro-
scopic and crystallographic data, the Fe(III) in the resting
state is five-coordinate, including a bridging (hydr)oxo
ligand; the M(II) site is likely to be six-coordinate with a
terminal water molecule completing its first coordination
sphere [13]. The enzyme thus provides an asymmetric
binuclear active site with an NO4 Fe(III) site and an N2O4
divalent metal site (Fig. 1).
All PAPs are believed to employ variants of a similar
basic mechanism to catalyze the hydrolysis of monophos-
phate ester bonds [1, 2, 14]. In the proposed models for
catalysis, the identity of the attacking nucleophile, the
structure of the transition state and the relative contribution
of the metal ions to PAP reactivity all vary. This reflects
the differences in metal ion composition, the protonation
state of metal-bound water molecules and structural vari-
ations in the immediate vicinity of the binuclear metal
center. A recent study has shown that PAPs are likely to
employ a flexible mechanistic strategy (‘‘one enzyme–two
mechanisms’’) whereby the metal ion composition, the
second coordination sphere and the substrate itself affect
the catalytic mechanism [15]. It could be demonstrated that
native di-iron pig PAP (uteroferrin, Uf) hydrolyzes both
ester bonds of a diester substrate in a sequential manner,
indicating that two nucleophiles are operational in this
enzyme, one terminally bound to the trivalent metal ion,
the other one bridging the irons [16]. Furthermore, the
replacement of the Fe(III) by Ga(III) leads to a change in
the identity of the reaction-initiating nucleophile for the
hydrolysis of the monoester substrate para-nitrophenyl
phosphate (pNPP), from the terminal to the bridging
hydroxide [15]. Thus, the Ga(III) derivative of Uf employs
a mechanism similar to that proposed for the Fe(III)Mn(II)
sweet potato PAP (Scheme 1) [9, 14]. No crystallographic
data that may provide insight into structural changes that
occur owing to the metal ion replacements in Uf are cur-
rently available. However, with fluoride as an inhibitory
probe, it has recently been shown that the active-site
structure of Uf is likely to represent an equilibrium
between a conformation susceptible to fluoride and one that
is not, an observation that suggests some structural flexi-
bility [17]. This flexibility may be associated with an
exposed loop close to the active site; proteolytic cleavage
within this loop has been shown to alter both reactivity and
substrate specificity [18, 19].
From the above discussion it follows that replacement of
the trivalent metal ion in Uf may alter the molecular
mechanism of catalysis by possibly inducing subtle struc-
tural changes in the active site. In contrast, in the best
characterized derivative of Uf, where the Fe(II) has been
exchanged by Zn(II), the metal ion replacement does not
appear to affect the catalytic properties of the enzyme
significantly [15]. While this may indicate that the divalent
metal binding site is less susceptible to structural changes,
it should also be noted that other divalent metal ions (e.g.,
Cu(II), Co(II), Mn(II) and Hg(II) [20, 21]) induce more
significant catalytic changes. A similar observation was
reported for the PAP from red kidney bean, where the
substitution of the native Zn(II) by Fe(II) does not lead to
significant changes in catalytic performance [22], but other
derivatives are considerably less reactive [23]. Here, we
decided to probe the role of the divalent metal ion in Uf by
replacing the native iron by Ni(II) and monitoring the
catalytic effects caused by this substitution. Of interest is
the effect of this substitution on pKa values associated with
the hydrolytic reaction since a comparison between the
native enzyme and the derivatives may aid in the identifi-
cation of ligands and residues important in catalysis.
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Fig. 1 The active site of purple acid phosphatases (PAPs). Residue
labels refer to the sequence of pig PAP (uteroferrin, Uf)
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Biomimetics provide an additional method to probe the
role of a metal ion in a catalytic cycle. A series of iso-
structural Fe(III)M(II) complexes (M is Fe, Mn, Cu, Zn)
that mimic the coordination environment of PAPs, and that
have the characteristic purple/pink color, have recently
been described [24–31]. Of particular interest is the
observation that at least in the Fe(III)Zn(II) complex, the
best characterized of these mimics, only the terminal,
Fe(III)-bound hydroxide is sufficiently strong a nucleophile
to induce catalysis [28]. Thus, the proposed reaction
mechanism for the mimetic is similar to that employed by
native Uf and its Fe(III)Zn(II) derivative (Scheme 1). Here,
we report physicochemical properties for relevant Ni(II)
derivatives, and compare them with those of both the iso-
structural complexes and the corresponding Fe(III)Ni(II)
derivative of Uf, Fe(III)Ni(III)–Uf. Implications for the
catalytic activity are discussed.
Materials and methods
Materials
All reagents were of analytical grade and were purchased
from Sigma-Aldrich unless otherwise stated.
Purification and characterization of Uf
Uf was extracted from the uterine fluid of a pregnant sow
as described elsewhere [32]. Protein concentrations were
determined by measuring the absorbance at 280 nm using
the specific absorbance of 1.41 for a 1 mg mL–1 solution of
Uf (e = 49,350 M–1 cm–1). The rates of product formation
using Uf were determined at 298 K using a continuous
assay with pNPP as the substrate. Assays were undertaken
at pH values between 3.8 and 7.0, using 100 mM glycine,
acetate or 2-morpholinoethanesulfonic acid (MES) buffer.
Product (para-nitrophenol, pNP) formation was monitored
at 390 nm. Substrate concentrations ranged from 0.1 to
10 mM. Assays were performed with a Varian Cary50
UV–vis spectrophotometer with 1-cm pathlength quartz
cuvettes.
Preparation of the Fe(III)Ni(II) metal ion derivative
of Uf [Fe(III)Ni(II)–Uf]
In order to prepare half apoenzyme Uf (500 lL of
16 mg mL–1 in acetate buffer, pH 4.90), 5 mM 1,10-phe-
nanthroline and 100 mM sodium dithionite were mixed
(Vtot = 3 mL) and incubated at room temperature for
1 min. Subsequently, the mixture was loaded onto a 3-mL
Bio-Rad Econo-Pac 10 DG column (pre-equilibrated with
acetate buffer, pH 4.90). To the half apoenzyme 100 equiv
of Ni(II) [as Ni(OAc)2] was added and the mixture was
incubated at room temperature for several days. The
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Scheme 1 Proposed mechanisms for purple acid phosphatase (PAP)
catalyzed phosphorolysis. Amino acid residue and metal ion labels
refer to the Ga(III)Zn(II) derivative of uteroferrin [15]. In one model,
the initial coordination of the substrate to the divalent metal ion is
followed by a nucleophilic attack by the l-(hydr)oxide. Following the
release of the alcohol product (ROH) a minimum of two water
molecules are required to regenerate the active site. In an alternative
scheme a terminal, Fe(III)-bound hydroxide is believed to be the
nucleophile (see text for details). (Adapted from [15])
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activity of the enzyme was monitored periodically and after
maximum activity was reached, the excess metal ions were
removed by dialysis. Metal ion analysis by atomic
absorption spectroscopy indicated a stoichiometric amount
of iron and 0.8 Ni(II) ions per active site, and only trace
amounts of Zn(II), Cu(II) and Mn(II).
Preparation of biomimetic complexes
(Caution! Perchlorate salts of metal complexes are
potentially explosive and therefore should be prepared in
small quantities.)
The ligand 2-bis[{(2-pyridylmethyl)aminomethyl}-6-
{(2-hydroxybenzyl)(2-pyridylmethyl)}aminomethyl]-4-me-
thylphenol (H2bpbpmp; Fig. 2) and the complex [FeNi
(bpbpmp)(l-OAc)2](ClO4) (1) were prepared as described
previously [29–31].
Preparation of [Fe(III)Ni(II)(bpbpmp)(l-OAc)(H2O)2]
[ClO4]22H2O (2)
A violet solution was obtained when 0.36 g (1 mmol) of
Ni(ClO4)2, 0.51 g of Fe(ClO4)39H2O (1 mmol) and 0.13 g
of NaOAc3H2O (1 mmol) were added to a solution of
0.54 g (1 mmol) of the unsymmetric ligand H2bpbpmp
[24] in 20 mL of methanol, at 333 K. The microcrystalline
precipitate was recrystallized in an ethyl acetate/methanol
(1:1 v/v) solution and crystals of [Fe(III)Ni(II)(bpbpmp)(l-
OAc)(H2O)2](ClO4)22H2O (2) suitable for X-ray analysis
were obtained. Yield: 0.97 g (98%). Anal. Calcd for
C36H45Cl2N5O16FeNi: C 43.76, H 4.59, N 7.09. Found: C
43.3, H 4.5, N 7.0%.
Preparation of [Fe(III)Ni(II)(bpbpmp)(OH)(H2O)3]
(ClO4)23H2O (3)
To a methanolic solution containing 0.17 g of complex 1,
1.58 mL of an aqueous solution of LiOH (0.30 mol L–1)
was added. The formation of [Fe(III)Ni(II)(bpbpmp)
(OH)(H2O)3](ClO4)23H2O (3) was followed by observing
the spectroscopic changes. A red microcrystalline precipi-
tate was formed and, after recrystallization in methanol,
crystals suitable for X-ray analysis were obtained. Yield:
0.14 g (76%). Anal. Calcd for C34H46Cl2N5O17FeNi: C
41.58, H 4.72, N 7.13. Found: C 42.0, H 4.7, N 7.2%.
Complex 3 can also be obtained by reacting 0.54 g
(1 mmol) of H2bpbpmp previously dissolved in 20 mL of
methanol (333 K), with 0.36 g (1 mmol) of Ni(ClO4)2
6H2O and 0.51 g (1 mmol) of Fe(ClO4)39H2O followed
by the addition of sodium perchlorate dissolved in water
(0.11 g, 1 mmol) under stirring and heating. Crystals
suitable for X-ray analysis were obtained after allowing the
solution to stand. Yield: 0.64 g (70%). Anal. Calcd for
C34H46Cl2N5O17FeNi: C 41.58, H 4.72, N 7.13. Found: C
41.3, H 4.6, N 7.1%.
Potentiometric titrations of biomimetic complexes
The potentiometric studies were carried out with a Mic-
ronal B375 pH meter fitted with blue-glass and calomel
reference electrodes calibrated to read –log [H+] directly,
designated as pH. Double-distilled water in the presence of
KMnO4 and reagent-grade ethanol were used to prepare the
ethanol/water (70:30, v/v) solutions. The electrode was
calibrated using the data obtained from the potentiometric
titration of a known volume of a standard 0.100 M HCl
solution with a standard 0.100 M KOH solution. The ionic
strength of the HCl solution was maintained at 0.100 M by
addition of KCl. The measurements were carried out in a
thermostated cell containing a solution of the complex
(0.05 mol per 50 mL) with ionic strength adjusted to
0.100 M by addition of KCl, at 298.00 ± 0.05 K. The
experiments were performed under argon flow to eliminate
the presence of atmospheric CO2. The samples were titra-
ted by addition of fixed volumes of a standard CO2-free
KOH solution (0.100 M). Computations were carried out
with the BEST program, and species diagrams were plotted
with SPE and SPEPLOT programs [33].
X-ray crystallographic analysis of biomimetic
complexes
The data were collected with a CAD-4 diffractometer
using the x-2h scan method. Data reduction was carried
HON N
N N N
OH
Fig. 2 2-Bis[{(2-pyridylmethyl)aminomethyl}-6-{(2-hydroxyben-
zyl)(2-pyridylmethyl)}aminomethyl]-4-methylphenol (H2bpbpmp)
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out with HELENA [34] and an empirical absorption
correction (W scan) was performed with PLATON
[35, 36]. The structures were solved by direct methods
and refined by full-matrix least-squares methods using
SHELXS-97 [37] and SHELXL-97 [38] programs,
respectively. The hydrogen atoms of the water solvates
were found from a Fourier difference map and treated
with a riding model. The hydrogen atoms bonded to
carbon atoms were placed at idealized positions using
standard geometric criteria. Non-hydrogen atoms were
refined with anisotropic displacement parameters, except
for the oxygen atoms of the perchlorate counterion for 3,
which was disordered, with three oxygen atoms occupying
two alternative positions. Crystal data are listed in
Table 1; selected bond distances and angles are given in
Tables 2 and 3. Crystallographic data (without structure
factors) for the structure(s) reported in this paper have
been deposited with the Cambridge Crystallographic
Data Centre (CCDC) as supplementary publication nos.
CCDC-654237 and CCDC-654238. Copies of the data can
be obtained free of charge from the CCDC (12 Union
Road, Cambridge CB2 1EZ, UK; Tel.: +44-1223-336408;
Fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk;
Web site http://www.ccdc.cam.ac.uk).
Magnetic susceptibility of biomimetic complexes
Magnetic susceptibility measurements were carried out at
the School of Chemistry, Monash University, Australia,
using a Quantum Design MPMS SQUID magnetometer
with an applied field of 1 T as a function of temperature
(ranging from 2 to 300 K). The crystalline samples were
enclosed in a calibrated gelatine capsule positioned in the
center of a drinking straw fixed to the end of the sample
rod. Effective magnetic moments, per mole, were calcu-
lated using the relationship leff = 2.828(vmT)
1/2, where vm
is the susceptibility per mole of complex.
Table 1 Crystallographic and
refinement data for
Fe(III)Ni(II)(bpbpmp)(l-
OAc)(H2O)2](ClO4)22H2O (2)
and [Fe(III)Ni(II)(bpbpmp)
(OH)(H2O)3](ClO4)23H2O (3)
H2bpbpmp is 2-bis[{(2-
pyridylmethyl)aminomethyl}-6-
{(2-hydroxybenzyl)(2-
pyridylmethyl)}aminomethyl]-
4-methylphenol
2 3
Empirical formula C36H44Cl2N5O16FeNi C34H44Cl2N5O16FeNi
Formula weight 988.22 964.20
Temperature (K) 293(2) 293 (2)
Wavelength (A˚) 0.71073 0.71073
Crystal system Monoclinic Triclinic
Space group P21/n P-1
a (A˚) 11.233(2) 11.257 (2)
b (A˚) 13.942(3) 12.813 (3)
c (A˚) 27.593)(5) 15.506 (3)
a () 103.77 (3)
b () 98.61(3) 99.52 (3)
c () 93.43 (3)
Volume (A˚3) 4,272.7 2,130.8
Z 4 2
Dcalc (mg m
–3) 1.536 1.503
l (mm–1) 0.981 0.981
F (000) 2,044 998
H () 2.54–25.07 2.40–25.07
Index ranges –13 £ h £ 13 0 £ h £ 13
–16 £ k £ 0 –15 £ k £ 15
–32 £ l £ 0 –18 £ l £ 18
Reflections collected 7,750 7,980
Independent reflection 7,548 [R(int) = 0.0287] 7,557 [R(int) = 0.0142]
Refinement method Full-matrix least squares on F2 Full-matrix least squares on F2
Data/restraints/parameters 7,584/0/550 7,557/48/530
Goodness of fit on F2 1.048 1.045
Final R indices [I [ 2r(I)] R1 = 0.0494, wR2 = 0.1307 R1 = 0.0513, wR2 = 0.1474
R indices (all data) R1 = 0.1005, wR2 = 0.1650 R1 = 0.0880, wR2 = 0.1681
Largest diffraction peak
and hole (e A˚–3)
0.958 and –0.790 0.745 and –0.619
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Kinetic assays of Fe(III)Ni(II)–Uf and biomimetic
complexes
For Fe(III)Ni(II)–Uf all kinetic experiments were con-
ducted with a Varian Cary50 UV–vis spectrophotometer at
298 K unless specified otherwise, using 1-mL quartz cuv-
ettes with 1-cm pathlength. A continuous assay was used to
determine kinetic constants for Uf with pNPP as the sub-
strate. The rate of formation of product (pNP) was
measured at 390 nm over 1 min. The extinction coefficient
of pNP in 0.1 M acetate buffer (pH 4.90) was determined
as 342.9 M–1 cm–1. Different concentrations of substrates,
ranging from 0.5 to 10 mM, were assayed in 1 mL reaction
mixtures in 0.1 M acetate buffer, pH 4.9 (final enzyme
concentration 50 nM). Assay mixtures were incubated at
298 K for 2 min prior to the addition of enzyme. Data were
analyzed using WinCurveFit (Kevin Raner Software). A
range of buffers (100 mM acetate and MES) were used to
cover the pH regions 3.8–5.5 and 5.2–7.0, respectively. The
change in molar absorption coefficient at 390 nm, De, was
determined at each pH in experiments in which pNPP
(5 mM) was hydrolyzed to completion (enzyme concen-
tration 2 lM) at room temperature. The solution of pNP
which resulted from this reaction was diluted in buffer to a
concentration of 0.2 mM pNP, and the absorbances of the
mixtures were measured against 0.2 mM pNPP in each
buffer at a wavelength of 390 nm.
For the biomimetic systems phosphatase-like activity
was determined by measuring hydrolysis of the substrate
2,4-bis(dinitrophenyl)phosphate (2,4-bdNPP) at 400 nm
(e = 12,100 M–1 cm–1) [29]. Reactions were monitored to
less than 5% of conversion of substrate to product, and the
data were treated by the initial rate method. The effect of
pH on the rate of hydrolysis of 2,4-bdNPP between pH 3.0
and 9.0 was investigated by using fixed concentrations of
substrate (2.0 mM) and complex (4.0 · 10–5 M). The
complex was preincubated (10 min) by diluting a stock
solution of the complex in the appropriate buffer at the
desired pH at 298 K (I = 0.05 M with LiClO4). Substrate
dependence of the catalytic rate was measured at optimum
pH (pH 6.8) and analyzed by nonlinear regression and a
Lineweaver–Burk plot (both methods resulted in, within
experimental error, identical parameters).
Spectroscopic measurements of Fe(III)Ni(II)–Uf
and biomimetic complexes
X-ray absorption data collection was performed at KEK,
Tskuba, beamline BL-20B. Data were collected for both the
Table 2 Selected bond distances (A˚ngstrom) and angles (degrees)
for 2
Fe1–O20 1.902 (3) Fe1–O61 1.973 (3)
Fe1–O1 1.982 (3) Fe1–O1W 2.103 (3)
Fe1–N32 2.124 (4) Fe1–N1 2.175 (4)
Fe1–Ni1 3.5166 (11) Ni1–N52 2.054 (4)
Ni1–O2W 2.061 (3) Ni1–N42 2.073 (4)
Ni1–O62 2.074 (3) Ni1–N4 2.087 (4)
Ni1–O1 2.095 (3)
O20–Fe1–O61 95.16 (15) O20–Fe1–O1 99.01 (14)
O61–Fe1–O1 93.68 (13) O20–Fe1–O1W 89.89 (15)
O61–Fe1–O1W 88.21 (14) O1–Fe1–O1W 170.69 (14)
O20–Fe1–N32 167.23 (15) O61–Fe1–N32 96.29 (15)
O1–Fe1–N32 85.90 (13) O1W–Fe1–N32 84.83 (14)
O20–Fe1–N1 89.35 (16) O61–Fe1–N1 173.21 (15)
O1–Fe1–N1 90.62 (14) O1W–Fe1–N1 86.72 (15)
N32–Fe1–N1 78.77 (15) N52–Ni1–O2W 92.97 (16)
N52–Ni1–N42 95.65 (16) O2W–Ni1–N42 94.08 (16)
N52–Ni1–O62 174.64 (15) O2W–Ni1–O62 91.71 (14)
N42–Ni1–O62 86.62 (15) N52–Ni1–N4 83.14 (16)
O2W–Ni1–N4 173.03 (14) N42–Ni1–N4 80.60 (17)
O62–Ni1–N4 92.46 (14) N52–Ni1–O1 87.89 (14)
O2–W Ni1–O1 93.32 (13) N42–Ni1–O1 171.61 (15)
O62–Ni1–O1 89.22 (13) N4–Ni1–O1 92.31 (14)
Fe1–O1–Ni1 119.17 (15)
Table 3 Selected bond distances (A˚ngstrom) and angles (degrees)
for 3
Ni1–Fe1 3.6838 (14) Ni1–O4W 2.026 (3)
Ni1–N42 2.057 (4) Ni1–N52 2.064 (4)
Ni1–N4 2.069 (4) Ni1–O3W 2.106 (3)
Ni1–O10 2.161 (3) Fe1–O20 1.911 (3)
Fe1–O1W 1.916 (3) Fe1–O10 2.007 (3)
Fe1–O2W 2.077 (3) Fe1–N32 2.131 (4)
Fe1–N1 2.167 (4)
O4W–Ni1–N42 95.37 (15) O4W–Ni1–N52 95.52 (15)
N42–Ni1–N52 96.46 (16) O4W Ni1–N4 175.50 (14)
N42–Ni1–N4 83.62 (16) N52–Ni1–N4 80.26 (16)
O4W–Ni1–O3W 90.36 (14) N42–Ni1–O3W 171.71 (14)
N52–Ni1–O3W 88.92 (15) N4–Ni1–O3W 91.11 (15)
O4W–Ni1–O10 92.13 (13) N42–Ni1–O10 85.57 (13)
N52–Ni1–O10 171.85 (14) N4–Ni1–O10 92.16 (13)
O3W–Ni1–O10 88.24 (13) O20–Fe1–O1W 97.38 (14)
O20–Fe1–O10 97.98 (14) O1W–Fe1–O10 89.92 (12)
O20–Fe1–O2W 89.83 (14) O1W–Fe1–O2W 88.73 (13)
O10–Fe1–O2W 172.18 (13) O20–Fe1–N32 166.78 (15)
O1W–Fe1–N32 94.25 (14) O10–Fe1–N32 88.29 (14)
O2W–Fe1–N32 84.14 (15) O20–Fe1–N1 89.52 (15)
O1W–Fe1–N1 172.14 (14) O10–Fe1–N1 92.85 (14)
O2W–Fe1–N1 87.53 (14) N32–Fe1–N1 78.50 (15)
Fe1–O10–Ni1 124.20 (14)
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solid and the dissolved state of 3 (70:30 acetonitrile/water
solution at a concentration of approximately 1 mM) in
fluorescence mode at 10 K. In the solid state the sample was
mixed with boron nitride at an appropriate concentration for
a 70% edge drop. X-ray absorption spectra at the iron K-edge
were collected between 6.89 and 8.00 keV. The extended X-
ray absorption fine structure (EXAFS) was obtained after
background removal using the program Athena [39]. Further
data analysis was carried out with the program Artemis [39],
where the k3-weighted data were fitted to a model based on
atom shells. For each shell the average bond distance and
Debye–Waller factor were fitted using single-scattering
EXAFS theory based on FEFF 6.0. These parameters were
restrained to physically reasonable values.
Electronic absorption spectra were collected with a
Varian Cary50 spectrophotometer at 298 K in the range
250–800 nm, with the biomimetics dissolved in acetonitrile
and the Fe(III)Ni(II) derivative of Uf in 100 mM acetate
buffer, pH 4.9. Magnetic circular dichroism (MCD)
measurements were conducted with a Spex1402 mono-
chromator equipped with an SM-4 Oxford magneto-optical
cryostat. A Varian SpectrAA 220FS atomic absorption
spectrometer was used to determine the concentration of
protein-bound metal ions.
Cyclic voltammetry of Fe(III)Ni(II)–Uf and biomimetic
complexes
Electrochemical measurements with Fe(III)Ni(II)–Uf were
conducted with a BAS 100B/W electrochemical analyzer
and a BAS C3 cell stand. The electrode used was an edge
plane pyrolytic graphite working electrode prepared as
described elsewhere [3]. A platinum wire was used as the
counter electrode and the reference electrode was Ag/AgCl
for all experiments. The potentials reported herein are versus
the normal hydrogen electrode (NHE), achieved using a
196-mV correction for the potential of the reference elec-
trode. The working electrode film was prepared by
combining 10 lL of a 300 lM protein solution with 10 lL
of 5 mM dimethyldidodecylammonium bromide in a sam-
ple tube. A 10-lL aliquot of this solution was subsequently
added to the electrode surface and dried overnight at 277 K.
Electrochemical measurements were conducted at 298 K in
500 lL of a mixed buffer solution containing 100 mM
sodium acetate, 100 mM MES and 100 mM glycine. The pH
range 3.1–7.0 was achieved through titration of appropriate
amounts of sodium hydroxide, acetic acid or hydrochloric
acid. The cyclic voltammetry scan rates were between 20
and 200 mV s–1 and the square wave voltammetry had a 2-
mV step potential, 8-mV amplitude and a frequency of 5 Hz.
For the biomimetic complexes cyclic voltammograms
were recorded with a Princeton Applied Research 273
system at room temperature under an argon atmosphere in
organic solvents, with tetrabutylammonium hexafluoro-
phosphate as the supporting electrolyte. The experiments
were carried out by employing a standard three-component
system: a platinum working electrode; a platinum wire
auxiliary electrode; an Ag/AgCl pseudoreference electrode.
To monitor the reference electrode, the ferrocenium/fer-
rocene (Fc+/Fc) couple was used; potentials are reported
relative to the Fc/Fc+ couple. Typically, scan rates of 50,
75 and 100 mV s–1 were employed.
Results and discussion
Fe(III)Ni(II) derivative of Uf; reconstitution
of enzyme activity
Treatment of Uf with the reductant dithionite and the che-
lator 1,10-phenanthroline effectively removes the divalent
iron, while the chromophoric trivalent iron remains largely
bound to the protein. Metal ion analysis indicated that the
half apoenzyme contained 0.85 (±0.06) Fe per active site,
with a residual activity of kcat = 1 s
–1 (approximately
0.25% of the value determined for the fully active di-iron
enzyme [40]). Reconstitution of enzyme activity following
the addition of excess Ni(II) was monitored using the
standard continuous assay at pH 4.90. After 25 h of incu-
bation the activity increase reached a plateau with a kcat of
6.3 s–1. After a lag period of approximately 24 h the activity
started to rise further to a final activity of kcat = 61.5 s
–1
after approximately 200 h. The result suggests biphasic
behavior where initial rapid metal ion uptake is followed by
a slower conformational rearrangement of the active site in
order to adopt a structure optimal for catalytic transforma-
tions. In order to test this hypothesis, an aliquot of half
apoenzyme was incubated for 10 h with excess Ni(II).
When the activity reached the initial plateau (kcat = 6 s
–1)
excess Ni(II) was removed by gel filtration and the metal
ion content of the protein sample was determined to be 0.75
Fe and 0.72 Ni. A second aliquot of the half apoenzyme was
incubated until maximum activity (kcat = 61.5 s
–1) was
reached (approximately 220 h) and the metal ion content
was determined to be 0.78 Fe and 0.86 Ni, similar to that of
the first aliquot, suggesting that metal ion uptake into the
active site is relatively rapid but the reconstitution of a
catalytically fully functional active site is slow.
Electronic absorption spectroscopy of Fe(III)Ni(II)–Uf
The major feature of the absorption spectrum of Fe(III)-
Ni(II)–Uf (Table 4) is a band at 275 nm attributed to the
absorption of aromatic amino acids. Transitions observed
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at 330 and 506 nm are associated with the characteristic
charge transfer transition observed in PAPs; for example,
Fe(III)Fe(II)–Uf displays an absorption band at 510 nm [1,
2, 20]. Other derivatives of Uf have similar kmax and e,
ranging from 514 nm and 3,350 M–1 cm–1 for the Mn(II)
analog to 525 nm and 3,580 M–1 cm–1 for Fe(III)Zn(II)–Uf
[20], which suggests that the electronic structure of the
chromophoric site in PAPs is well conserved.
Electrochemical properties of Fe(III)Ni(II)–Uf
The cyclic voltammogram of Fe(III)Ni(II)–Uf at pH 5.0
indicates a reversible redox potential at 557 mV. The linear
dependence of the current on the scan rate is indicative of
an electron transfer process localized on the electrode
surface [3]. The absence of a shift in the potential over a
range of scan rates, a constant peak width at half height and
a reasonably uniform cathodic and anodic peak current
suggests that electron transfer in Fe(III)Ni(II)–Uf is a rapid
process unaffected by any coupled reactions. For compar-
ative purposes voltammetric data were also collected for
native Uf. Both sets of data show a linear pH dependence
of the redox potentials; while the pH dependence of the
redox potentials of the derivative is similar to that observed
for the native enzyme, the potentials are shifted to
approximately 180 mV higher values. Since this potential
is thus not likely to be due to the chromophoric Fe(III)/
Fe(II) couple, and since the M(II) site does not have strong
electron donors to stabilize Ni(III) [41], it is hypothesized
that the observed potential in the derivative is associated
with the oxidation of the tyrosinate ligand involved in the
formation of the ligand to metal charge transfer (LMCT)
complex (Tyr55; Fig. 1). This redox reaction apparently is
not observed in the native enzyme, possibly owing to the
oxidation of the nonchromophoric iron. It has been shown
that upon oxidation of native Uf to the inactive di-iron(III)
form the strength of the tyrosine–Fe(III) bond is increased
[12], which greatly stabilizes the tyrosine ligand in its
reduced form (i.e., its redox potential is significantly
increased).
Kinetic properties of Fe(III)Ni(II)–Uf
Previous metal replacement studies have shown that
replacement of Fe(II) by Zn(II) in pig and bovine PAPs can
be achieved without significant loss of activity [20, 42].
Table 4 Spectroscopic, susceptibility, potentiometric and kinetic data for Fe(III)Ni(II)–Uf (Uf is uteroferrin), [FeNi(bpbpmp)(l-OAc)2](ClO4)
1, 2, 3 and related complexes
kmax (nm)
(e M–1 cm–1)
pKe1 pKe2 pKes1 pKes2 Ks (mM) kcat (s
–1) J (cm–1)
Fe(III)Fe(II)–Uf [2] 510 (4,450) 2.3 4.8 4.2 6.1 1.2 431 –5 to –11
Fe(III)Ni(II)–Uf 506 (3,150); 330;
275 (49,350)
– 5.6 4.9 5.9 1.4 61.5
kmax (nm)
(e M–1 cm–1)
pKa1 pKa2 pKa3 Km (mM) kcat (s
–1) J (cm–1) E1/2 (V)
Fe(III)/
Fe(II)
Epc (V)
Ni(II)/
Ni(I)
E1/2 (V)
Ni(III)/
Ni(II)
1 [22] 930 (25); 538 (4,813);
328 (5,562)
5.30 6.80 8.61 3.8 · 10–3 4.8 · 10–4 –13.3 (gFe = 1.98,
gNi = 2.077)
–0.94 –1.41 +0.76
2 930 (10); 545 (4,234);
321 (5,700)
4.80 6.65 8.01 1.1 · 10–2 8.7 · 10–4 –13.2 (gFe = 1.981,
gNi = 2.110)
–0.48 –0.98
3 932 (20); 522 (2,603);
324 (3,780)
4.30 4.90 8.10 1.2 · 10–2 9.0 · 10–4 –13.7 (gFe = 1.98,
gNi = 2.110)
–0.58 –1.22
[FeFe(bpbpmp)
(l-OAc)2]
+ [24]
1,050 (60); 555 (4,560) –7.4 –0.89
[FeMn(bpbpmp)
(l-OAc)2]
+ [25]
544 (2,680) 5.80 7.76 2.1 · 10–3 7.1 · 10–4 –6.8 –0.87
[FeZn(bpbpmp)
(l-OAc)2]
+ [27]
540 (3,700) 4.86 6.00 7.22 8.1 · 10–3 11.0 · 10–4 –0.91
[FeCu(bpbpmp)
(l-OAc)2]
+ [26]
546 (3,400); 330 5.25 6.20 7.82 1.1 · 10–2 18.0 · 10–4 –1.0
[Ni2(Hbpbpmp)
(l-OAc)2]
+ [59]
–1.24 +0.59
146 J Biol Inorg Chem (2008) 13:139–155
123
Replacement with Mn(II), Cu(II) and Co(II) leads to
only partial reconstitution of enzyme activity [20, 21].
Similarly, the Ni(II) derivative of Uf reaches only
approximately 15% of the activity of the native enzyme
(Table 4). This reduction in activity is not likely to be due
to variations in Lewis acidity between the divalent ions
since Cu(II) and Mn(II) derivatives of Uf have activities
similar to that of the Ni(II) derivative, despite the fact that
Cu(II) and Ni(II) are stronger Lewis acids than Fe(II),
which in turn is stronger than Mn(II) (the pKa values for
hexaaqua complexes of Cu(II), Ni(II), Fe(II) and Mn(II) are
7.5, 9.4, 10.1 and 10.7, respectively [43]).
The pH dependences of kcat and kcat/Km for FeNi–Uf
have been assessed (Fig. 3, Table 4). At least two proton-
ation equilibria are relevant factors determining the
reactivity (kcat), while for the catalytic efficiency (kcat/Km)
only the alkaline limb is resolved. The pH dependences of
kcat and kcat/Km were analyzed using Eqs. 1 and 2 [44], and
the pKa values for the relevant equilibria are listed in
Table 4, together with the corresponding pKa values
determined for native Fe(III)Fe(II)–Uf [40]. Note that
Eqs. 1 and 2 were derived using diprotic and monoprotic
models, respectively [44]. Kes values represent protonation
equilibria for the enzyme–substrate complex, and Ke is
associated with a protonation equilibrium in the free
enzyme or substrate. Ks describes the equilibrium of the
interaction between enzyme and substrate.
kcatðobsÞ ¼ kcat
1 þ ½HþKes1 þ Kes2½Hþ
ð1Þ
kcat
Km
ðobsÞ ¼ kcat
Ks 1 þ Ke2½Hþ
  ð2Þ
In the comparison between the Fe(III)Fe(II) and
Fe(III)Ni(II) forms of Uf the pKa least affected by the metal
ion substitution is pKes2, suggesting that the corresponding
equilibrium involves a residue which is not directly coor-
dinated to the divalent metal ion. In agreement with
previous studies [40, 45–47] pKes2 is assigned to a con-
served histidine residue in the second coordination sphere,
which is likely to act as a proton donor to the leaving
alcohol group during catalysis [14, 47–49]. Site-directed
mutagenesis studies identified His92 as the likely residue
[47]. In the protonated form the imidazole side chains are
positively charged, thus increasing the binding affinity of
the negatively charged phosphate group of the substrate.
Deprotonation of the imidazole group leads to a loss of
positive charge, consistent with the observed increase in
Km at high pH.
The remaining pKa values (pKes1 and pKe2) are signifi-
cantly altered by the metal ion substitution (Table 4), as
would be expected for protonation equilibria of ligands that
are directly coordinated to the divalent metal ion. In
comparison with the native Fe(III)Fe(II) form of Uf each
pKa in the Fe(III)Ni(II) derivative is shifted towards more
alkaline values, resulting in a corresponding shift of the pH
for optimum reactivity from 5.0 to 5.5 upon replacing
Fe(II) with Ni(II). Based on an inspection of the active site
of the enzyme and previous studies [40, 46, 47], the fol-
lowing assignment is proposed:
pKe2 ¼ 5:6 : pNPPH pNPP2 þ Hþ;
pKes1 ¼ 4:9 : l-OH  l-O2 þ Hþ:
The assignment of pKe2 to the deprotonation of the
substrate (pNPP) suggests a preferential binding of the
substrate in its monoanionic form, while assigning pKes1 to
the bridging hydroxide supports a role for this ligand as a
reaction-initiating nucleophile. Alternatively, pKes1 could
be assigned to the deprotonation of a terminal Fe(III)-
bound water molecule. However, the absence of this water
ligand in resting Uf [13] make this assignment less likely.
Also, the significant change of pKes1 upon replacing Fe(II)
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Fig. 3 pH dependence of the kinetic parameters of Fe(III)Ni(II)–Uf.
The data for the Fe(III)Ni(II) derivative of Uf (squares) were
compared with those reported for the native Fe(III)Fe(II) form
(circles) [40]. The data were fitted using Eqs. 1 and 2
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by Ni(II) (Table 4) indicates that the corresponding ligand
is coordinated to the divalent metal ion.
Synthesis and X-ray crystal structure of binuclear
Fe(III)Ni(II) biomimetics of Uf
Reaction between 1 mmol of H2bpbpmp and 1 mmol of
Ni(ClO4)26H2O in methanol followed by addition of
1 mmol of Fe(ClO4)39H2O and 2 mmol of sodium acetate
results in the formation of [FeNi(bpbpmp)(l-OAc)2](ClO4)
(1), a compound in which the cation is isostructural with
similar heterodinuclear mixed-valence [FeIIIMII(bpbpmp)
(l-OAc)2]
+ (MII is Zn, Cu) complexes [26, 27]. In the
presence of only 1 mmol of sodium acetate the mono
l-OAc complex [Fe(III)Ni(II)(bpbpmp)(l-OAc)(H2O)2]
(ClO4)22H2O (2) is obtained. Stoichiometric reaction of
H2bpbpmp, Ni(ClO4)26H2O and Fe(ClO4)39H2O in
methanol, in the presence of perchlorate anion, results in
the isolation of [FeNi(bpbpmp)(OH)(H2O)3](ClO4)23H2O
(3).
The X-ray structure of 2 (Fig. 4) shows that the Ni(II)
ion is coordinated to bpbpmp2– through one amine (N4)
and two pyridine (N42 and N52) donors. The Fe(III) ion is
coordinated through the tertiary amine (N1) and pyridine
(N32) and to the oxygen atom of the deprotonated terminal
phenol. One exogenous acetate and one endogenous phe-
noxo group bridge the two metal ions. The distorted
octahedral coordination sphere around the Fe(III) and
Ni(II) centers is completed with one water molecule bound
to each metal ion. The structure of 2 therefore represents a
good functional model for metallophosphatases, since one
of the acetate bridges in 1 (Fig. 4) is substituted by the
coordination of two water molecules.
The Fe(III)–Ni(II) distance in 2 is 3.5166(11) A˚, similar
to that found for [Fe(III)Zn(II)(bpbpmp)(l-OAc)2]
2+
[3.490(9) A˚] [27] and for 1 [3.486(13) A˚] [29]. The main
structural difference between 1 and 2 lies in the mode of the
coordination of the tridentate N2O pendant arm of bpbpmp
2–
to the Fe(III) center. In 1 this group is facially bound to
Fe(III), but is meridionally bound in 2. Consequently, in 2
the terminal Fe(III)-bound phenoxo group is in a trans
position to the pyridine nitrogen atom [Fe–N32 distance is
2.124(7) A˚], whereas in 1 this group is in a trans position to
the oxygen atom from the phenoxo bridge [Fe1–O distance
is 1.995(3) A˚]. Nevertheless, this change results in only a
slight decrease in the bond length Fe–O20 [1.902(3) A˚] for 2
compared with 1 [1.905(3) A˚], consistent with a greater
Lewis acidity of the Fe(III) center in the former. A water
molecule in a trans position to the phenoxo bridge completes
the coordination sphere of the Fe(III) center.
The Fe–Ophenoxo–Ni angle [119.17(15)] in 2 is similar
to that found in 1 [118.66(15)] and slightly greater than
that found for [Fe(III)Ni(II)(BPMP)(OPr)2]
2+ [116.2(2)],
where BPMP is the anion of 2,6-bis[(bis(2-pyridylmethyl)
amino)methyl]-4-methylphenol [50]. The distances between
the metal centers and the phenoxo bridge are also only
slightly different in 2 [Fe1–O1 distance 1.982(3) A˚ and
Ni1–O1 distance 2.095(13) A˚] and in 1 [Fe1–O distance
1.995(3) A˚ and Ni1–O1 distance 2.058(3) A˚]. The oxygen
acetate atoms are unsymmetrically coordinated to metal
centers in 2 [Fe1–O61 distance 1.973(3) A˚; Ni1–O62 dis-
tance 2.074(3) A˚].
The X-ray structure of complex 3 (Fig. 4) shows that the
ligand is coordinated to the Ni(II) center in a facial mode
and meridionally to the Fe(III). There is no acetate bridge
and the metal ions are bound only to the phenoxo bridge
from the bpbpmp2– ligand. The Ni(II) is coordinated to two
pyridines and a tertiary amine, and the N3O3 coordination
sphere is completed by two water molecules and the phe-
noxo bridge. The Fe(III) center is in an N2O4 coordination
Fig. 4 Top: Crystal structure of [Fe(III)Ni(II)(bpbpmp)(l-
OAc)(H2O)2](ClO4)22H2O (2). Bottom: Crystal structure of
[FeNi(bpbpmp)(OH)(H2O)3](ClO4)23H2O (3)
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environment composed of a pyridine and an amine nitrogen
atom (N32 and N1, respectively) and a terminal phenoxo
group (O20); the other coordination positions are occupied
by a water molecule and a hydroxo group. Completing the
heterodinuclear coordination sphere is the phenoxo oxygen
originating from the bpbpmp2– ligand, forming a bridge
between the two distorted octahedral metal centers. The
terminal hydroxo group is strongly bound to the Fe(III)
center [Fe(III)–O distance 1.916(3) A˚]. There is consider-
able asymmetry in 3, not only owing to the different
coordination spheres around the two centers but also owing
to the asymmetric arrangement of the phenoxo bridge with
Fe(III)–Ophenoxo [2.007(3) A˚] and Ni(II)–Ophenoxo [2.161(3)
A˚]. The Fe(III)–Ni(II) bond distance is 3.6838(14) A˚,
longer than that found in 1 [3.486(13) A˚], 2 [3.5166(11) A˚]
and PAPs (approximately 3.3 A˚ [2, 14, 45, 48]). The dis-
tance is comparable to those found for [Fe2(bpbp)
(F)2(H2O)](BF4) [3.726(2) A˚] and [FeCu(bpbp)(F)2(H2O)]
(BF4) [3.828(1) A˚], where Hbpbp is 2,6-bis{bis(2-pyr-
idylmethyl)aminomethyl}-4-tert-butylphenol [51, 52]. The
terminal Fe–Ophenolate distance [1.911(3) A˚] in 3 is similar
to that found in 1 [1.905(3) A˚] and 2 [1.902(3) A˚], though it
is significantly smaller than the value found for red kidney
bean PAP (Fe–Ophenolate distance 2.05 A˚) [48].
The Fe–Ophenoxo–Ni angle in 3 is 124.20(14), greater
than those found for 1 [118.66(15)] and 2 [119.17(15)];
however, it is similar to those found in other heterovalent
compounds [Fe2(bpbp)(F)2(H2O)](BF4) [124.6(3)] and
[FeCu(bpbp)(F)2(H2O)](BF4) [126.72(10)] that contain a
fluoride ion, considered isoelectronic to the hydroxo ion
[51, 52].
The most significant characteristic of this structure is the
presence of a hydroxo group coordinated to the Fe(III)
center in a cis position to a water molecule coordinated to
the Ni(II) center. The presence of a nucleophile group, such
as a hydroxo, is an important factor in studying the activity
of these compounds in the hydrolysis of phosphate esters or
diesters. These features lead to 3 being a very good
structural model, and possibly a functional model, for PAPs
and related metallohydrolases.
Magnetic susceptibility of Fe(III)Ni(II) biomimetics
of Uf
The magnetic properties of complexes 1, 2 and 3 are
reported in the form of vMT versus T plots in a field of 1 T
for the three complexes (Figs. 5, S1). In each case at 300 K
the moment (approximately 6.20 lB) is lower than expec-
ted for uncoupled Fe(III)Ni(II) (S = 5/2; S = 1) ions
(gav = 2.0). The leff values uniformly decrease from
300 K, reaching 3.66 lB at 2 K indicative of antiferro-
magnetic coupling and a ground state with S = 3/2 for the
systems. Analysis of the data for the complexes was based
on the Hamiltonian H = –2JS1S2 using previously reported
procedures taking into account the contributions of the
individual gFe and gNi values [53, 54]. The exchange
coupling constants are of similar magnitude in the three
complexes (for 3, J = –13.7 cm–1, gFe = 1.98 and gNi =
2.11; R = 3.7454 · 10–4; Table 4). R, the function mini-
mized in the curve fitting, was R = R(vm
obs – vm
calc)2/
R(vm
obs)2. The magnitude of the antiferromagnetic coupling
is comparable to that determined for the complex [Fe(III)
Ni(II)(BPMP)(OPr)2](BPh4)2 (J = –12.5 cm
–1) [50]. The
data suggest that the major pathway for exchange coupling
is mediated via the phenoxide bridge and that the acetate
groups have very little effect on the magnetic properties of
the binuclear center. The magnitude of |J| for 2 and 3 is
consistent with the crystal structure (Fig. 4) showing the
presence of only one oxo bridge, from the phenoxide, and
the absence of l-O2– or l-OH–.
Electronic absorption spectroscopy and MCD
of Fe(III)Ni(II) biomimetics of Uf
Electronic spectra of 1, 2 and 3, dissolved in acetonitrile,
are shown in Fig. 6 and data are given in Table 4. The
broad feature between 520 and 560 nm is attributed to the
terminal phenolate to Fe(III) LMCT transition, character-
istic of isostructural model complexes [24–31] and PAPs
[1, 2, 10–12]. The kmax (and corresponding extinction
coefficients) for 1, 2 and 3 (Tables 4 and S1) are similar to
those determined for both related model complexes and
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Fig. 5 vMT versus T for 2. The data were fitted with a Van Vleck
expression derived for an SFe = 5/2, SNi = 1 system and including no
zero-field-splitting-fitting term. While this approach may not accom-
modate variations at very low temperatures it does allow
determination of the magnitude and sign of J [53]
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PAPs. Hence, the model complexes can be considered as
good synthetic analogs for the chromophoric site of the
protein systems. The observed increase in energy for the
LMCT transition in 3 indicates a reduction in the effective
nuclear charge of the ferric ion with a concomitant increase
in the energy of the d orbitals [12]. Furthermore, the lower
intensity of this transition in 3 is also consistent with a
weakening of the bond between the terminal phenolate
ligand and Fe(III). Finally, a weak band observed at
approximately 930 nm in all three complexes is ascribed to
a Ni(II) 3A2g ?
3T2g d ? d transition (data not shown).
MCD spectra (450–700 nm) of the three model com-
plexes were recorded at 4.2 K at a magnetic field of 5 T
(Fig. 6). The observed transitions in this energy region are
associated with the charge transfer complex as discussed
above. The temperature dependence of the bands at 5 T
was also determined and demonstrated that the main con-
tribution to the signal is the C-term [55–57] as expected for
a ground-state Kramers doublet of an odd-electron system.
The MCD spectrum of 2 is clearly distinct from those of 1
and 3, with one dominant band and two weaker transitions
(Fig. 6). The origin of the difference is not immediately
apparent and the MCD of these, and similar complexes, is
under further examination. Assuming that the conforma-
tions in the X-ray structures are retained in solution, the
differences may reflect the unusual position of the terminal
01x02 3
51
b)
a)
01
5
0
A
00003000520000200051
51
01
5
0
5-
01-
∆A
01x02 3
51
01
5
0
A
00003000520000200051
51
01
5
0
-5
-10
∆A
01x01 3
8
6
4
2
0
A
00003000520000200051
mc[rebmunevaw 1- ]
01-
5-
0
5
01
∆A
c)
Fig. 6 The room-temperature
absorption (lower) and low-
temperature magnetic circular
dichroism (MCD; upper)
spectra of a [FeNi(bpbpmp)(l-
OAc)2](ClO4) (1) (a), 2 (b) and
3 (c). Gaussian resolution was
made simultaneously on MCD
and absorption spectra.
Absorption spectra were
measured in acetonitrile, while
MCD samples were in a
methanol/ethanol glass at 4.2 K,
5 T. Additional transitions
associated with the charge
transfer band are anticipated in
the high-energy region
(approximately 30,000 cm–1)
[12] but were not observed
owing to instrumental
limitations
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Fe(III)-bound phenoxo group being cis to the bridging
phenoxo in 2, rather than trans in the structures of 1 and 3.
For the complexes the short phenoxy–iron bond defines
the axes of the Fe(III) d orbitals. There are a total of four
electronic transitions expected in this region corresponding
to an electron being promoted from the two p orbitals
localized on the phenolate ligand to the two t2g orbitals, dxz
and dyz, which participate with p-bonding to the largest
extent and are predicted to have the greatest intensity [12].
These p orbitals on the phenolate ligand actually exhibit
mixed r/p bonding character, depending on the particular
orientation of the phenolate plane. Thus, two additional
bands, due to the pop, pip ? dz2 transitions, are also
expected at higher energy. The Gaussian resolution of the
broad MCD peak requires a minimum of three fitted
Gaussian bands. If the Gaussian fit is made simultaneously
to both absorption and MCD data sets, common peak
positions can be used to reduce the number of parameters
to be fitted, while areas and widths are allowed to vary
[58]. There are approximations in this modeling approach
in using low-temperature MCD and room-temperature
absorption spectra. The low-temperature absorption spectra
did not show any major differences from the room-tem-
perature spectra, apart from a slight sharpening of the
bands. However, there were some baseline and scattering
effects in the low-temperature absorption spectra that are
inherent in the nature of frozen-glass samples, which
makes it preferable to use the room-temperature absorption
spectra in the fitting process. In all cases the MCD spectra
show the band maxima at lower energy than in the
absorption spectrum. Fixing the three peak positions from
the MCD, we required a fourth peak in the absorption
spectrum. Details of the fit (Table S1) imply that splitting
of the dxz, dyz orbitals (of the order 1,000–2,000 cm
–1) is
less than that of the pop, pip orbitals (2,000–3,000 cm
–1).
Two additional peaks were fitted to higher energy, one
appearing as a shoulder at approximately 30,000 cm–1 and
the other at approximately 25,000 cm–1. The weighted
average of these two peaks minus that of the four peaks at
lower energy is approximately 10,000 cm–1 and corre-
sponds to the effective octahedral splitting of the eg and t2g
orbitals on the FeIII.
Electrochemistry of Fe(III)Ni(II) biomimetics of Uf
Electrochemical data for 1 [29], 2 and 3 and relevant
parameters are presented in Table 4 and Fig. S2. Com-
plexes 1 and 2 reveal quasi-reversible behavior for the
Fe(III)Ni(II)/Fe(II)Ni(II) redox process. The differences
between the redox potentials for complexes 1, 2 and 3 can
be ascribed to the different acidities of the Fe(III) centers in
these complexes. The anodic shift of 0.46 V observed
between complexes 1 and 2 is due to the exchange of one
acetate for a water molecule, which lowers the electronic
density of the Fe(III) center. Contrastingly, the presence of
the hydroxo group in 3 increases the electronic density of
the Fe(III) center, thus promoting a cathodic shift when
compared with complex 2.
Comparison of the potential of the Fe(III)Ni(II)/Fe(II)-
Ni(II) couple in 1 with those observed for similar
[Fe(III)M(II)(bpbpmp)(l-OAc)2]
+ complexes [M(II) is Fe,
Mn and Zn; Table 4] shows that only small displacements
for this process are observed, in agreement with the com-
mon coordination environment around the Fe(III) [24–31].
The voltammograms of 1, 2 and 3 show one irreversible
cathodic wave comparable to the Ni(II)Ni(II)/Ni(II)Ni(I)
redox process observed in the [Ni2(II)(Hbpbpmp)(l-
OAc)2]
+ complex [59] (Table 4), and which is assigned to
the Fe(II)Ni(II)/Fe(II)Ni(I) nickel-centered process. The
redox process observed at E1/2 = +0.76 V for 1 is anodic-
shifted by approximately 0.2 V but is still comparable with
the Ni(III)Ni(II)/Ni(II)Ni(II) redox couple found for the
corresponding Ni2(II) complex (+0.59 V vs Fc
+/Fc) [59].
Interestingly, this process was not observed for complexes
2 and 3, most probably because it is anodic-shifted in
relation to complex 3 and therefore out of the investigated
potential range (–1.4 to +1.4 V).
The [Fe(III)Fe(II)(bpbpmp)(OAc)2]
+ complex [31] and
Uf [3, 4] show similar redox potentials for the Fe(III)-
Fe(III)/Fe(III)Fe(II) redox process, which suggests a
similar Lewis acidity of the Fe(II) center in both species. It
is proposed that the reversible redox potential at +0.557 V
for Fe(III)Ni(II)–Uf is associated with the oxidation of the
tyrosinate (Tyr55) ligand involved in the LMCT transition
instead of the Ni(II)/Ni(III) oxidation process (vide supra).
This proposal is in full agreement with the redox properties
of the biomimetic complex 3, which does not show any
redox process in the 0.0–1.0-V (vs NHE) range. Impor-
tantly, in biomimetic systems, stable phenoxyl radical
complexes with some electrochemical response are nor-
mally generated when the bound phenolate ligand is
adequately protected by bulky substituents (tert-butyl)
[60].
X-ray absorption spectroscopy of 3
Iron K-edge EXAFS spectra collected for 3 in both solid
and dissolved states are shown in Fig. 7. The correspond-
ing fits of the EXAFS data k3v(k) and the Fourier transform
v(R) data are also shown. The metal–metal distance
determined from these data is 3.72 A˚, in good agreement
with the crystallographic metal–metal distance of 3.684 A˚.
In a 70:30 acetonitrile/water solution the metal–metal
distance determined by EXAFS was found to be 3.73 A˚,
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indicating that the overall structure of the binuclear center
remains intact in aqueous solution.
Potentiometric equilibrium determination
of Fe(III)Ni(II) biomimetics of Uf
Potentiometric titration studies with 2 and 3 (in a 30:70
water/ethanol solution) showed the neutralization of 3 mol
KOH mol–1 in the pH range 4–10; corresponding pKa
values are shown in Table 4 (data for 1 were determined
previously [29]). The release of the acetate group in solu-
tion in 1 and 2 is associated with its lability [27, 61] and
promotes the coordination of water molecules to the Fe(III)
center. pKa1 and pKa2 in 1 and 2 are attributed to the de-
protonation of the water molecules bound to the Fe(III)
center. On the other hand, it is assumed that the coordi-
nation environment around the Fe(III) and Ni(II) in 3 is
maintained in aqueous solution since under the experi-
mental conditions only the dinucleating ligand and H2O/
OH– molecules occupy the first coordination sphere of the
Fe(III) and Ni(II) centers. This proposal is in full agree-
ment with the EXAFS data in solution which reveal that the
FeNi distance of approximately 3.7 A˚ obtained from the
X-ray structure of 3 is maintained when the complex is
dissolved in acetronitile/water (Fig. 7). Therefore, we
propose the equilibria shown in Scheme 2.
Deprotonation of the Fe(III)-bound water molecule
(pKa1 = 4.30) in a cis position to a water molecule coor-
dinated to the Ni(II) center is anticipated on the basis of the
structure of 3, which reveals that this coordination position
is occupied by a hydroxide ligand. pKa values at 4.90 and
8.10 found for 3 are assigned to deprotonation of the sec-
ond Fe–H2O molecule and to deprotonation of one of the
Ni(II)–H2O molecules, respectively. Interestingly, the pKa
of 4.80 determined for 2 compares favorably with the
Fig. 7 a Solid-state k3v(k) and
v(R) extended X-ray absorption
fine structure (EXAFS) data and
corresponding fits for 3. The
metal–metal distance
determined from the EXAFS
data is 3.719 A˚, which
correlates well with
crystallographic data showing a
metal–metal distance of
3.684 A˚. b Dissolved-state
k3v(k) and v(R) EXAFS data
and corresponding fits for 3. The
metal–metal distance
determined (3.735 A˚) is similar
to that determined for the solid
state, indicating the complex
maintains its structural integrity
upon dissolution
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second pKa of 4.90 found for 3, indicating that this de-
protonation/protonation process is most probably related to
the water molecule which is in a trans position to the
bridging phenolate in both complexes. The pKa1 of 5.30
determined for 1 is approximately 0.5 pH units higher than
the values found for 2 and 3.
Phosphatase-like activity of Fe(III)Ni(II) biomimetics
of Uf
The phosphatase-like activity of the three model systems
was measured under conditions of excess substrate, using
the activated substrate 2,4-bdNPP. Complexes 1, 2 and 3
possess the following important kinetic features: (1) labile
sites—carboxylate bridge(s) in 1 and 2; (2) water mole-
cules coordinated to the Fe(III) and Ni(II) centers—
complexes 2 and 3; (3) the presence of a hydroxo group
coordinated to the Fe(III) center—complex 3; (4) low pKa
values for one of the water molecules coordinated to the
Fe(III) center, generating a good nucleophile. This last
characteristic is present in all three complexes, as can be
observed in the pKa values obtained (Table 4) and the pH
of optimal activity observed for the hydrolysis of the
diester substrate 2,4-bdNPP.
The catalytic activity of the three model systems was
investigated in the pH range 3.0–9.0 (Fig. S3). The pH
values for optimal activity are 6.0, 6.5 and 6.0 for com-
plexes 1 [29], 2 and 3, respectively, in agreement with
those found for similar complexes [25–31] and for PAPs
[2, 6, 8, 14, 40, 42, 46, 49]. Using Eq. 1, we determined
pKes1 values of 4.9, 4.9 and 5.1 and pKes2 values of 8.3, 7.8
and 7.5 for 1, 2 and 3, respectively. For 1 and 2 pKes1 and
pKes2 are in good agreement with pKa1 and pKa3 obtained
from the potentiometric titrations (Table 4). In contrast, for
3, pKes1 and pKes2 are comparable with pKa2 and pKa3. This
difference may be associated with the substitution of the
water molecule at the Fe(III) site in 3 by 2,4-bdNPP. This
substitution is expected to provoke an increase in the
electronic density on Fe(III), lowering its Lewis acidity and
raising the pKa of the hydroxo group coordinated to this
metal site.
The dependence of the initial rates, at optimal pH, on the
concentration of the substrate reveals saturation kinetics
with Michaelis–Menten-like behavior [44] (Fig. S4). The
resulting kcat and KM are listed in Table 4. The reactions
catalyzed by the three systems are likely to be initiated by
the terminal hydroxo group coordinated to the Fe(III)
center. The lower activity of 1 compared with 2 and 3 may
be related, at least in part, to the competitive inhibition due
to the acetate bridge in solution, and/or to structural dif-
ferences of the active species when the complexes are
dissolved. The reactivities of 2 and 3 are similar and
indicate that the catalytically relevant species of these two
complexes, in solution, are likely to exhibit similar
geometries and ligand coordination.
Conclusions
The data presented for the Fe(III)Ni(II) derivative of Uf
supports a mechanistic model whereby initial binding of
the substrate is followed by a nucleophilic attack by a
metal ion bridging (hydr)oxide (Scheme 1). This mecha-
nistic scheme is similar to that proposed for the
Fe(III)Mn(II) sweet potato PAP [2, 9, 14] and the
Ga(III)Zn(II) derivative of Uf [15], but is in contrast to that
reported for the Fe(III)Fe(II) and Fe(III)Zn(II) forms of Uf
and the Fe(III)Zn(II) red kidney bean PAP [15, 48, 49],
which employs a terminal, Fe(III)-bound hydroxide as a
nucleophile. From a comparison of experimental data for
various derivatives of Uf it emerges thus that the metal ion
composition may influence the precise catalytic strategy
employed by the enyzme to hydrolyze ester bonds. Both
the terminal, Fe(III)-bound and the metal ion bridging
hydroxides can act as reaction-initiating nucleophiles
depending on the metal ion composition. Structural chan-
ges in the active site of Uf induced by different
coordination geometry preferences for different metal ions
are likely to be the cause for these mechanistic variations.
This hypothesis is further supported by the recent obser-
vation that Uf is able to hydrolyze, in sequence, both ester
bonds of the diester substrate methyl-pNPP [16]; the ter-
minal hydroxide initiates hydrolysis of the first ester bond,
while the bridging hydroxide initiates cleavage of the
second bond.
The isostructural Fe(III)M(II) biomimetics presented
here and elsewhere [24–31] provide good structural, but
also reasonable functional models for both types of enzy-
matic mechanisms. In contrast to Fe(III)Ni(II)–Uf, the
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three FeNi models described in this study employ a ter-
minal Fe(III)-bound hydroxide as a nucleophile
(Scheme 3), similar to the isostructural Fe(III)Zn(II)
complex [28]. Thus, metal ion composition does not seem
to be the only factor affecting the mechanism of hydrolysis.
The specific comparison between the Ni(II)-containing
derivatives of Uf and biomimetics illustrates that identical
metal composition does not lead to the same mechanism,
an observation which highlights the significance of the
dynamic ligand environment in the protein active site for
the optimization of the catalytic efficiency.
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